S252: M2-POLARIZED MACROPHAGES CONTROL LEUKEMIC STEM CELL FATE BY PROMOTING METABOLIC REPROGRAMMING

• I. Weinhäuser,
• D. A. Pereira-Martins,
• J. R. Hilberink,
• L. Y. Almeida,
• D. R. A. Silveira,
• L. Quek,
• S. M Hogeling,
• J. M. Mota,
• E. Ammatuna,
• A. R. Lucena-Araujo,
• G. A. Huls,
• E. M. Rego,
• J. J. Schuringa

Affiliations

I. Weinhäuser

1 Experimental Hematology, University medical centre groningen, Groningen, Netherlands

D. A. Pereira-Martins

1 Experimental Hematology, University medical centre groningen, Groningen, Netherlands

J. R. Hilberink

1 Experimental Hematology, University medical centre groningen, Groningen, Netherlands

L. Y. Almeida

2 Center for Cell Based Therapy, University of Sao Paulo

D. R. A. Silveira

4 Myeloid Leukaemia Genomics and Biology Group, Kings College London, London, United Kingdom

L. Quek

4 Myeloid Leukaemia Genomics and Biology Group, Kings College London, London, United Kingdom

S. M Hogeling

1 Experimental Hematology, University medical centre groningen, Groningen, Netherlands

J. M. Mota

5 Medical Oncology Service, Sao Paulo State Cancer Institute, Sao Paulo

E. Ammatuna

1 Experimental Hematology, University medical centre groningen, Groningen, Netherlands

A. R. Lucena-Araujo

6 Department of Genetics, Federal University of Pernambuco, Recife

G. A. Huls

1 Experimental Hematology, University medical centre groningen, Groningen, Netherlands

E. M. Rego

7 Center for Cell Based Therapy, University of Sao Paulo, Sao Paulo, Brazil

J. J. Schuringa

1 Experimental Hematology, University medical centre groningen, Groningen, Netherlands